Labcorp offers comprehensive testing options across the neurodegenerative spectrum

Neurofilament Light Chain (NfL) Test

NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.

Glial Fibrillary Acidic Protein (GFAP)

GFAP is a protein expressed mostly in astrocytes in the brain that has utility in predicting disability progression in multiple sclerosis, determining the extent of damage in traumatic brain injury events and, in conjunction with markers of amyloid pathology, has been shown to be a predictor of Alzheimer’s disease.

Advancing Alzheimer's disease diagnostics

Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.

Multiple Sclerosis (MS)

While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.

ALS / Ataxias / Huntington’s disease

Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.

Muscular Dystrophy

Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.

Helping develop new biopharma breakthroughs

The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into therapeutic solutions and related neurodegenerative biomarkers.